NONOates--polyethylenimine hydrogel for controlled nitric oxide release and cell proliferation modulation

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Vascular Biology

Background:

• Nitric oxide (NO) is a critical signaling molecule with therapeutic potential, particularly as a restenosis inhibitor.
• Restenosis involves vascular smooth muscle cell proliferation, endothelial cell apoptosis, and platelet aggregation.
• Controlled NO release systems are needed for localized therapeutic delivery.

Purpose of the Study:

• To develop a novel nitric oxide (NO)-conjugated gel system for controlled NO release.
• To investigate the potential of this system as a restenosis inhibitor by evaluating its effects on vascular cells.
• To assess the biocompatibility and release kinetics of the NO-conjugated gel.

Main Methods:

• Synthesis of a thermosensitive gel system (F127-BPEI-NONOates) by conjugating Pluronic F127, branched polyethylenimine (BPEI), and diazeniumdiolates (NONOates).
• Characterization of NO release profiles, including initial burst reduction and prolonged release.
• Evaluation of the polymer's effect on endothelial and smooth muscle cell proliferation in vitro using cell culture dishes.

Main Results:

• The synthesized F127-BPEI-NONOates gel demonstrated reduced initial burst and sustained release of NO.
• The NO-releasing polymer coating significantly increased endothelial cell proliferation.
• The polymer coating effectively reduced smooth muscle cell proliferation compared to controls.

Conclusions:

• The developed NO-conjugated gel system offers controlled and prolonged nitric oxide release.
• This system shows significant potential for inhibiting restenosis by modulating vascular cell behavior.
• The high biocompatibility of the Pluronic F127 component suggests broad biomedical application possibilities.